Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
IRB00114240
Unknown gene_therapy active
Quick answer
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx" for Cancer is a Unknown program (gene_therapy) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Cancer
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active